Investigating the cardiovascular benefits of wild rice consumption
A Multidisciplinary Investigation of Cardiovascular Benefits of Wild Rice
This study is testing whether eating wild rice every day for a month can improve heart health in healthy adults.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 48 (estimated) |
| Ages | 20 Years to 40 Years |
| Sex | All |
| Sponsor | University of Manitoba Academic / other |
| Locations | 1 site (Winnipeg, Manitoba) |
| Trial ID | NCT04119791 on ClinicalTrials.gov |
What this trial studies
This study involves 24 healthy adult males and females who will consume approximately 30 grams of wild rice daily for 28 days. The primary aim is to assess the impact of wild rice on cardiovascular risk factors before and after the intervention. The study is designed as a pilot to explore the potential health benefits of wild rice, which has not been previously tested in clinical trials. The research is conducted by the Department of Food and Human Nutritional Sciences at the University of Manitoba, known for its contributions to food and nutrition research.
Who should consider this trial
Good fit: Ideal candidates for this study are healthy adults aged 20 to 40 years, both male and female.
Not a fit: Patients who are pregnant, lactating, smokers, obese, or on medications for cardiovascular, diabetes, or cancer diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into dietary interventions that may reduce cardiovascular risk factors.
How similar studies have performed: While the effects of wild rice have not been tested in clinical trials, other studies on functional foods have shown promising results in improving health outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male * Female * Both genders are healthy * 20 - 40 years old Exclusion Criteria: * Non-pregnant * Non-lactating * Non-smokers * Not obese (Body Mass Index (BMI) \< 30) * Not currently on any medications for cardiovascular, diabetes, and cancer diseases
Where this trial is running
Winnipeg, Manitoba
- St. Boniface Hospital Research Center Asper clinical — Winnipeg, Manitoba, Canada (Recruiting)
Study contacts
- Principal investigator: Mohammed H Moghadasian, PhD — University of Manitoba
- Study coordinator: Mohammed H Moghadasian, PhD
- Email: mmoghadasian@sbrc.ca
- Phone: 204-235-3934
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.